Abstract
OBJECTIVES: To study occurrence of arterial thromboembolic events before and after breast cancer (BC) diagnosis compared to cancer-free controls as this information is lacking in published literature. METHODS: Women who had a first hospitalization for BC between 2002 and 2007 were selected from the PHARMO Record Linkage System, which includes drug use and hospitalization data of approximately 3 million residents in the The Netherlands. BC patients were matched 1:10 by age with cancerfree women, using the date of diagnosis as the index date for both BC patients and their controls. ATEE were defined as a myocardial infarction, ischemic stroke, unstable angina and transient ischemic attack requiring hospitalization and were assessed 12 months before and 12 months after the index date. RESULTS: The analysis included 11,473 BC patients, with a mean (±SD) age of 59 (±14) years. ATEE before the index date were twice as frequent among BC patients compared with cancer-free controls (Odds Ratio = 2.0[95%CI:1.6-2.6]), though prevalence was 10 days during the first 6 months of follow-up. CONCLUSIONS: In this population-based study, BC patients were twice as likely to develop ATEE compared to cancer-free controls, although the frequency of events was low. These results emphasize the need for careful observation of BC patients after diagnosis.
Original language | English |
---|---|
Pages | 26 |
Number of pages | 1 |
DOIs | |
Publication status | Published - 1-May-2010 |
Externally published | Yes |
Keywords
- anticoagulant agent
- cardiovascular agent
- antihypertensive agent
- antidiabetic agent
- human
- neoplasm
- society
- diagnosis
- pharmacoeconomics
- female
- breast cancer
- thromboembolism
- cancer patient
- outcomes research
- patient
- hospitalization
- risk
- drug use
- hazard ratio
- follow up
- Netherlands
- heart infarction
- brain ischemia
- unstable angina pectoris
- transient ischemic attack
- prevalence
- risk factor
- population
- cancer diagnosis